Sertoli cell tumor, a rare testicular tumor, our experience and review of the literature.
Arch Esp Urol
; 63(5): 392-5, 2010 Jun.
Article
en En, Es
| MEDLINE
| ID: mdl-20587845
ABSTRACT
OBJECTIVE:
We report two new cases of Sertoli cell testicular tumors, and a Cochrane and Medline search of cases published worldwide.METHODS:
We reviewed our series of testicular tumors, the stromal tumor incidence, clinical presentation, treatment and prognosis, and the experience reflected in the literature.RESULTS:
The prevalence of testicular tumors in our health area is of 0.09%, and 2.3% of them are Sertoli cell neoplasms. This figure is slightly higher than the found in other series in which Sertoli tumors range from 0.4% to 1.5% of testicular malignancies in adults and reach 4% in children.CONCLUSIONS:
Sertoli cell tumor has an incidence not exceeding 4%. The most common symptom is a painless mass; in cases with endocrine manifestation, up to 10% are malignant depending on the age of the patient.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Tumor de Células de Sertoli
/
Neoplasias Testiculares
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Humans
/
Male
/
Middle aged
Idioma:
En
/
Es
Revista:
Arch Esp Urol
Año:
2010
Tipo del documento:
Article